A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer

NCT02514681 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

226

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Locally Advanced or Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Docetaxel
DRUG: Paclitaxel
DRUG: Nab-paclitaxel
DRUG: Vinorelbine
DRUG: Eribulin
DRUG: Capecitabine
DRUG: Gemcitabine

Sponsor

Japan Breast Cancer Research Group

Collaborators

[object Object]